Stool Analysis After Sleeve Gastrectomy vs Gastric Bypass
ConditionMorbid Obesity
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorCairo University
About this trial
The goal of this observational study is to learn whether routine stool tests can detect changes in gut function 6 months after two common types of weight loss surgery: sleeve gastrectomy and gastric bypass (including mini gastric bypass and Roux-en-Y gastric bypass). The main questions it aims to answer are:
Do stool tests show more signs of undigested food or carbohydrate malabsorption after gastric bypass compared to sleeve gastrectomy?
Do signs of gut inflammation in stool (like fecal calprotectin) decrease after surgery, and does this relate to improvements in blood sugar and weight loss?
Can simple stool test results at 6 months predict how much weight a person loses or how well their diabetes improves?
Researchers will compare stool test results between the two surgery groups (sleeve gastrectomy vs. gastric bypass) to see if the type of surgery leads to different changes in gut health.
Participants will:
Provide a stool sample before surgery and again 6 months after surgery
Provide a blood sample at the same time points to measure weight, blood sugar, and cholesterol
Undergo their planned weight loss surgery as part of their regular medical care
Eligibility criteria
Qualifiers
Male and female patients aged 18 to 60 years
Body Mass Index (BMI) ≥ 40 kg/m², OR BMI ≥ 35 kg/m² with at least one obesity-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, osteoarthritis, obstructive sleep apnea)
Patients scheduled for primary laparoscopic bariatric surgery (either SG or Gastric Bypass [MGB or RYGB]) at Kasr Al-Ainy University Hospitals
Provision of written informed consent
Disqualifiers
Age < 18 years or > 60 years
Previous bariatric surgery or major gastrointestinal surgery (gastric, intestinal, or colorectal resection)
Chronic kidney disease (eGFR < 60 mL/min/1.73m²) or previous renal transplant
Chronic liver disease (cirrhosis, chronic hepatitis) or liver failure
Trial design
Treatments tested in this trial
- Laparoscopic Sleeve Gastrectomy
- Mini Gastric Bypass
- Roux-en-Y Gastric Bypass
Treatment groups
50 Participants
are divided into 2 treatment groupsLocations
1Faculty of Medicine Cairo University11956, CairoAl-Manial Cairo, Egypt
Sponsors and collaborators
Cairo University
Lead sponsor
Source ClinicalTrials.gov